SCHEDULE 13D/A · 2026-10-26
LeonaBio, Inc. has updated its Schedule 13D/A filing, revealing significant changes in its ownership structure and the influence of Perceptive Advisors LLC.
| Name | LeonaBio, Inc. |
|---|---|
| CIK | 0001620463 |
| Tickers | LONA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 453368487 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | (425) 620-8501 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
LeonaBio, Inc. has updated its Schedule 13D/A filing, revealing significant changes in its ownership structure and the influence of Perceptive Advisors LLC.
LeonaBio, Inc. discloses significant stock transactions involving directors and major shareholders, signaling potential strategic moves in the biological products sector.
472 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-463518 | 001-39503 | 261560874 | 34 | 12299291 | 1 | 1 | |
| 2026-11-16 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-463483 | 001-39503 | 261560686 | 34 | 323048 | 1 | 1 |
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-004525 | 005-91705 | 261552152 | 34 | 19098 | |||
| 2026-11-04 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-004856 | 005-91705 | 261521913 | 34 | 12903 | |||
| 2026-10-28 | 4 | PRIMARY DOCUMENT | 0002126186-26-000002 | 8350 | ||||||
| 2026-10-28 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001655566-26-000004 | 005-91705 | 261495537 | 34 | 14705 | |||
| 2026-10-26 | 4 | 4 | 0001193125-26-431896 | 20285 | ||||||
| 2026-10-26 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-431897 | 005-91705 | 261485866 | 34 | 10406 | |||
| 2026-09-22 | 8-K | 8-K | 8.01 | 0001193125-26-397952 | 001-39503 | 261397086 | 34 | 154713 | 1 | 1 |
| 2026-09-03 | 3 | PRIMARY DOCUMENT | 0002126186-26-000001 | 4704 | ||||||
| 2026-08-31 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001655566-26-000003 | 005-91705 | 261347008 | 34 | 1092055 | |||
| 2026-08-26 | 8-K | 8-K | 8.01 | 0001193125-26-368288 | 001-39503 | 261322685 | 34 | 159187 | 1 | 1 |
| 2026-08-25 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-365096 | 005-91705 | 261315610 | 34 | 12575 | |||
| 2026-08-20 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001636587-26-000069 | 005-91705 | 261297822 | 34 | 12642 | |||
| 2026-08-14 | 10-Q | 10-Q | 0001193125-26-352243 | 001-39503 | 261281615 | 34 | 11586409 | 1 | 1 | |
| 2026-08-14 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-352208 | 001-39503 | 261281408 | 34 | 338047 | 1 | 1 |
| 2026-07-10 | 4 | 4 | 0001193125-26-300876 | 10339 | ||||||
| 2026-07-09 | 4 | 4 | 0001193125-26-299927 | 10362 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100631.xml | 0001843393-26-000006 | 5982 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100652.xml | 0001580111-26-000010 | 6038 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100642.xml | 0001790314-26-000004 | 6000 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100601.xml | 0001679039-26-000003 | 5924 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100643.xml | 0001722055-26-000005 | 5868 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100602.xml | 0001164426-26-000003 | 5907 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100614.xml | 0001225501-26-000003 | 5916 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100627.xml | 0001763316-26-000004 | 5883 | ||||||
| 2026-06-24 | 4 | xslF345X06/form4-06242026_100648.xml | 0001258693-26-000011 | 5905 | ||||||
| 2026-06-23 | 8-K | 8-K | 5.07 | 0001193125-26-279425 | 001-39503 | 261111037 | 34 | 197412 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062870 | 005-91705 | 26990408 | 34 | 16122 | |||
| 2026-05-11 | ARS | ARS | 0001193125-26-217029 | 001-39503 | 26964201 | 34 | 5742295 | |||
| 2026-05-11 | DEFA14A | DEFA14A | 0001193125-26-217016 | 001-39503 | 26964135 | 34 | 1308715 | |||
| 2026-05-11 | DEF 14A | DEF 14A | 0001193125-26-216742 | 001-39503 | 26964036 | 34 | 4503439 | 1 | 1 | |
| 2026-05-07 | 4 | xslF345X06/form4-05082026_120559.xml | 0001580111-26-000007 | 5898 | ||||||
| 2026-05-07 | 4 | xslF345X06/form4-05082026_120552.xml | 0001790314-26-000003 | 5860 | ||||||
| 2026-05-07 | 4 | xslF345X06/form4-05082026_120544.xml | 0001843393-26-000004 | 5842 | ||||||
| 2026-05-07 | 3 | xslF345X06/form3-05082026_120509.xml | 0001790314-26-000002 | 12532 | ||||||
| 2026-05-07 | 3 | xslF345X06/form3-05082026_120521.xml | 0001580111-26-000006 | 12565 | ||||||
| 2026-05-07 | 3 | xslF345X06/form3-05082026_120524.xml | 0001843393-26-000003 | 12518 | ||||||
| 2026-05-07 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-212047 | 005-91705 | 26953743 | 34 | 12143 | |||
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-211898 | 001-39503 | 26953306 | 34 | 10602315 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-211867 | 001-39503 | 26953118 | 34 | 351609 | 1 | 1 |
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080418.xml | 0001679039-26-000002 | 5897 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080410.xml | 0001822499-26-000006 | 5868 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080453.xml | 0001763316-26-000002 | 5856 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080428.xml | 0001258693-26-000008 | 5878 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080426.xml | 0001722055-26-000004 | 5841 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080417.xml | 0001225501-26-000002 | 5889 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080406.xml | 0001164426-26-000002 | 5880 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080459.xml | 0001794629-26-000006 | 5881 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080445.xml | 0001191906-26-000002 | 5854 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080440.xml | 0001861464-26-000006 | 5878 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080430.xml | 0002037968-26-000006 | 5916 | ||||||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080417.xml | 0001604834-26-000008 | 5913 | ||||||
| 2026-04-02 | 424B3 | 424B3 | 0001193125-26-138620 | 333-292826 | 26830371 | 33 | 465559 | |||
| 2026-04-02 | 424B3 | 424B3 | 0001193125-26-138619 | 333-292829 | 26830370 | 33 | 290820 | |||
| 2026-04-01 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001046 | 333-292829 | 26830452 | 33 | 1906 | ||
| 2026-04-01 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001045 | 333-292826 | 26830451 | 33 | 1906 | ||
| 2026-04-01 | S-8 | S-8 | 0001193125-26-137879 | 333-294822 | 26828175 | 33 | 451848 | 1 | 1 | |
| 2026-04-01 | S-8 | S-8 | 0001193125-26-137873 | 333-294820 | 26828124 | 33 | 490844 | 1 | 1 | |
| 2026-03-31 | CORRESP | filename1.htm | 0001193125-26-134946 | 11596 | ||||||
| 2026-03-31 | CORRESP | filename1.htm | 0001193125-26-134930 | 11596 | ||||||
| 2026-03-31 | S-1/A | S-1/A | 0001193125-26-134904 | 333-292829 | 26823250 | 33 | 1076583 | 1 | 1 | |
| 2026-03-31 | S-1/A | S-1/A | 0001193125-26-134866 | 333-292826 | 26823115 | 33 | 1276106 | 1 | 1 | |
| 2026-03-31 | 10-K | 10-K | 0001193125-26-134565 | 001-39503 | 26821864 | 34 | 19207775 | 1 | 1 | |
| 2026-03-31 | 8-K/A | 8-K/A | 2.01,9.01 | 0001193125-26-134097 | 001-39503 | 26820625 | 34 | 1374313 | 1 | 1 |
| 2026-03-26 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-126579 | 001-39503 | 26799284 | 34 | 21180543 | 1 | 1 |
| 2026-03-19 | 8-K | 8-K | 5.02,5.07,8.01,9.01 | 0001193125-26-116123 | 001-39503 | 26774940 | 34 | 1012900 | 1 | 1 |
| 2026-03-10 | DEFR14A | DEFR14A | 0001193125-26-100178 | 001-39503 | 26739590 | 34 | 147367 | 1 | 1 | |
| 2026-03-05 | 4 | xslF345X05/form4-03062026_120343.xml | 0001604834-26-000006 | 12531 | ||||||
| 2026-03-05 | 4 | xslF345X05/form4-03062026_120318.xml | 0002037968-26-000004 | 9881 | ||||||
| 2026-03-05 | 4 | xslF345X05/form4-03062026_120320.xml | 0001861464-26-000004 | 9834 | ||||||
| 2026-03-05 | 4 | xslF345X05/form4-03062026_120346.xml | 0001822499-26-000004 | 9834 | ||||||
| 2026-03-05 | 4 | xslF345X05/form4-03052026_110324.xml | 0001794629-26-000004 | 9846 | ||||||
| 2026-03-04 | 144 | xsl144X01/primary_doc.xml | 0001604834-26-000004 | 001-39503 | 26723628 | 33 | 5628 | |||
| 2026-02-23 | DEF 14A | DEF 14A | 0001193125-26-063952 | 001-39503 | 26665094 | 34 | 3617753 | 1 | 1 | |
| 2026-02-20 | CORRESP | filename1.htm | 0001193125-26-061471 | 88724 | ||||||
| 2026-02-11 | UPLOAD | filename1.pdf | 0000000000-26-001440 | 333-292829 | 43601 | |||||
| 2026-02-11 | UPLOAD | filename1.pdf | 0000000000-26-001439 | 333-292826 | 43602 | |||||
| 2026-02-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001957912-26-000008 | 005-91705 | 26608083 | 34 | 17902 | |||
| 2026-02-04 | PRE 14A | PRE 14A | 0001193125-26-037767 | 001-39503 | 26599114 | 34 | 2339911 | 1 | 1 | |
| 2026-01-20 | S-3 | S-3 | 0001193125-26-016699 | 333-292829 | 26543497 | 33 | 1110852 | 1 | 1 | |
| 2026-01-20 | S-3 | S-3 | 0001193125-26-016629 | 333-292826 | 26543205 | 33 | 1953086 | 1 | 1 | |
| 2026-01-16 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-015471 | 005-91705 | 26540113 | 34 | 12425 | |||
| 2026-01-09 | 8-K | 8-K | 5.02,5.03,7.01,8.01,9.01 | 0001193125-26-008904 | 001-39503 | 26523094 | 34 | 1043766 | 1 | 1 |
| 2026-01-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001636587-26-000001 | 005-91705 | 26520710 | 34 | 12431 | |||
| 2026-01-05 | 4 | xslF345X05/form4-01062026_120132.xml | 0001794629-26-000002 | 10523 | ||||||
| 2026-01-05 | 4 | xslF345X05/form4-01062026_120146.xml | 0001604834-26-000002 | 13207 | ||||||
| 2026-01-05 | 4 | xslF345X05/form4-01062026_120150.xml | 0002037968-26-000002 | 12863 | ||||||
| 2026-01-05 | 4 | xslF345X05/form4-01062026_120110.xml | 0001822499-26-000002 | 12816 | ||||||
| 2026-01-05 | 4 | xslF345X05/form4-01062026_120121.xml | 0001861464-26-000002 | 10506 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091202.xml | 0002037968-25-000003 | 6367 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091231.xml | 0001604834-25-000004 | 6367 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091245.xml | 0001822499-25-000005 | 6319 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091206.xml | 0001794629-25-000003 | 6322 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091201.xml | 0001861464-25-000003 | 6319 | ||||||
| 2025-12-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-331145 | 005-91705 | 251601725 | 34 | 27702 | |||
| 2025-12-23 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000979 | 32462 | ||||||
| 2025-12-23 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001636587-25-000065 | 005-91705 | 251601330 | 34 | 12381 | |||
| 2025-12-22 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-328818 | 005-91705 | 251592829 | 34 | 15568 | |||
| 2025-12-18 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001373604-25-000127 | 005-91705 | 251582940 | 34 | 7636 | |||
| 2025-12-18 | 8-K/A | 8-K/A | 1.01,3.02,7.01,8.01,9.01 | 0001193125-25-323786 | 001-39503 | 251581368 | 34 | 27769071 | 1 | 1 |
| 2025-12-18 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-25-323692 | 001-39503 | 251581263 | 34 | 27256022 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001957912-25-000008 | 005-91705 | 251485931 | 34 | 17643 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-269544 | 001-39503 | 251458426 | 34 | 10766977 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-25-269506 | 001-39503 | 251458310 | 34 | 393450 | 1 | 1 |
| 2025-10-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001376474-25-000840 | 005-91705 | 251388505 | 34 | 9733 | |||
| 2025-10-03 | 8-K | 8-K | 8.01 | 0001193125-25-229293 | 001-39503 | 251372208 | 34 | 157867 | 1 | 1 |
| 2025-09-11 | 8-K | 8-K | 3.03,5.03,9.01 | 0000950170-25-114093 | 001-39503 | 251307315 | 34 | 300208 | 1 | 1 |
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-105052 | 001-39503 | 251194286 | 34 | 9098141 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-105029 | 001-39503 | 251194105 | 34 | 392507 | 1 | 1 |
| 2025-07-02 | 4 | xslF345X05/form4-07022025_080725.xml | 0001415889-25-019070 | 12261 | ||||||
| 2025-07-02 | 4 | xslF345X05/form4-07022025_080737.xml | 0001415889-25-019069 | 12619 | ||||||
| 2025-07-02 | 4 | xslF345X05/form4-07022025_080743.xml | 0001415889-25-019068 | 9971 | ||||||
| 2025-07-02 | 4 | xslF345X05/form4-07022025_080700.xml | 0001415889-25-019066 | 9960 | ||||||
| 2025-07-02 | 4 | xslF345X05/form4-07022025_080705.xml | 0001415889-25-019064 | 12311 | ||||||
| 2025-07-01 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-018810 | 001-39503 | 251097988 | 33 | 4753 | |||
| 2025-07-01 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-018808 | 001-39503 | 251097985 | 33 | 4669 | |||
| 2025-07-01 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-018806 | 001-39503 | 251097981 | 33 | 4654 | |||
| 2025-07-01 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-018804 | 001-39503 | 251097977 | 33 | 4663 | |||
| 2025-06-03 | 4 | xslF345X05/form4-06032025_090659.xml | 0001415889-25-015441 | 5549 | ||||||
| 2025-06-03 | 4 | xslF345X05/form4-06032025_090615.xml | 0001415889-25-015440 | 5653 | ||||||
| 2025-06-03 | 4 | xslF345X05/form4-06032025_090622.xml | 0001415889-25-015439 | 5683 | ||||||
| 2025-06-03 | 4 | xslF345X05/form4-06032025_090642.xml | 0001415889-25-015438 | 5689 | ||||||
| 2025-06-03 | 4 | xslF345X05/form4-06032025_090605.xml | 0001415889-25-015436 | 5681 | ||||||
| 2025-06-03 | 4 | xslF345X05/form4-06032025_090644.xml | 0001415889-25-015434 | 5642 | ||||||
| 2025-06-03 | 4 | xslF345X05/form4-06032025_090653.xml | 0001415889-25-015431 | 5687 | ||||||
| 2025-06-02 | 8-K | 8-K | 5.07 | 0000950170-25-080234 | 001-39503 | 251014918 | 34 | 174173 | 1 | 1 |
| 2025-05-09 | 10-Q | 10-Q | 0000950170-25-068040 | 001-39503 | 25930610 | 34 | 8274426 | 1 | 1 | |
| 2025-05-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-068020 | 001-39503 | 25930501 | 34 | 399231 | 1 | 1 |
| 2025-04-16 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-035511 | 005-91705 | 25843081 | 34 | 10598 | |||
| 2025-04-16 | 8-K | 8-K | 3.01 | 0000950170-25-054707 | 001-39503 | 25842734 | 34 | 171433 | 1 | 1 |
| 2025-04-14 | ARS | ARS | 0001140361-25-013774 | 001-39503 | 25836407 | 34 | 2901579 | |||
| 2025-04-14 | DEFA14A | DEFA14A | 0001140361-25-013773 | 001-39503 | 25836402 | 34 | 2607014 | |||
| 2025-04-14 | DEF 14A | DEF 14A | 0001140361-25-013769 | 001-39503 | 25836376 | 34 | 6549490 | 1 | 1 | |
| 2025-04-04 | PRE 14A | PRE 14A | 0001140361-25-012299 | 001-39503 | 25813887 | 34 | 6674657 | 1 | 1 | |
| 2025-03-12 | 4/A | xslF345X05/form4a-03122025_090335.xml | 0001415889-25-007858 | 6144 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_090322.xml | 0001415889-25-006553 | 10863 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_090334.xml | 0001415889-25-006552 | 8237 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_090341.xml | 0001415889-25-006536 | 8227 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_090304.xml | 0001415889-25-006534 | 8234 | ||||||
| 2025-03-04 | 4 | xslF345X05/form4-03042025_090321.xml | 0001415889-25-006531 | 8228 | ||||||
| 2025-02-27 | S-8 | S-8 | 0000950170-25-029109 | 333-285345 | 25679567 | 33 | 766606 | |||
| 2025-02-27 | 10-K | 10-K | 0000950170-25-029069 | 001-39503 | 25678994 | 34 | 16647631 | 1 | 1 | |
| 2025-02-27 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-029038 | 001-39503 | 25678804 | 34 | 379279 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001373604-25-000030 | 005-91705 | 25624474 | 34 | 7866 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001373604-25-000027 | 005-91705 | 25624265 | 34 | 7670 | |||
| 2025-01-03 | 4 | xslF345X05/form4-01032025_100122.xml | 0001415889-25-000544 | 9976 | ||||||
| 2025-01-03 | 4 | xslF345X05/form4-01032025_100106.xml | 0001415889-25-000536 | 12615 | ||||||
| 2025-01-03 | 4 | xslF345X05/form4-01032025_100111.xml | 0001415889-25-000534 | 12287 | ||||||
| 2025-01-03 | 4 | xslF345X05/form4-01032025_100141.xml | 0001415889-25-000527 | 12305 | ||||||
| 2025-01-03 | 4 | xslF345X05/form4-01032025_100141.xml | 0001415889-25-000525 | 12268 | ||||||
| 2025-01-02 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-000228 | 001-39503 | 25503529 | 33 | 4675 | |||
| 2025-01-02 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-000226 | 001-39503 | 25503525 | 33 | 4760 | |||
| 2025-01-02 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-000224 | 001-39503 | 25503522 | 33 | 4669 | |||
| 2025-01-02 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-000222 | 001-39503 | 25503519 | 33 | 4679 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-118955 | 005-91705 | 241462644 | 34 | 95011 | |||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123372 | 001-39503 | 241435962 | 34 | 7973186 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-123324 | 001-39503 | 241435719 | 34 | 312079 | 1 | 1 |
| 2024-11-07 | SC 13G | atha13g.htm | 0001373604-24-000108 | 005-91705 | 241434430 | 34 | 77725 | |||
| 2024-10-31 | SC 13D/A | SC 13D/A | 0001193125-24-248699 | 005-91705 | 241415451 | 34 | 72642 | |||
| 2024-10-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-10-28 16:00:00 | 9999999995-24-003298 | 333-282738 | 241402431 | 33 | 1828 | ||
| 2024-10-24 | UPLOAD | filename1.pdf | 0000000000-24-011896 | 333-282738 | 40136 | |||||
| 2024-10-24 | CORRESP | filename1.htm | 0000950170-24-116975 | 18143 | ||||||
| 2024-10-21 | S-3 | S-3 | 0000950170-24-115736 | 333-282738 | 241381924 | 33 | 1318699 | |||
| 2024-10-18 | 8-K | 8-K | 3.01,8.01 | 0000950170-24-115592 | 001-39503 | 241380749 | 34 | 170888 | 1 | 1 |
| 2024-10-07 | 8-K | 8-K | 5.02,9.01 | 0000950170-24-113210 | 001-39503 | 241357824 | 34 | 1716290 | 1 | 1 |
| 2024-10-03 | 4/A | xslF345X05/form4a-10042024_011037.xml | 0001415889-24-024712 | 5831 | ||||||
| 2024-10-03 | 4 | xslF345X05/form4-10032024_111030.xml | 0001415889-24-024686 | 8241 | ||||||
| 2024-10-03 | 4 | xslF345X05/form4-10032024_111055.xml | 0001415889-24-024685 | 8222 | ||||||
| 2024-10-03 | 4 | xslF345X05/form4-10032024_111019.xml | 0001415889-24-024684 | 8238 | ||||||
| 2024-10-03 | 4 | xslF345X05/form4-10032024_111033.xml | 0001415889-24-024683 | 8219 | ||||||
| 2024-10-03 | 4 | xslF345X05/form4-10032024_111021.xml | 0001415889-24-024680 | 8212 | ||||||
| 2024-10-03 | 3 | xslF345X02/form3-10032024_111049.xml | 0001415889-24-024678 | 17560 | ||||||
| 2024-09-17 | 8-K | 8-K | 2.05,5.02,9.01 | 0000950170-24-107031 | 001-39503 | 241302692 | 34 | 485393 | 1 | 1 |
| 2024-09-05 | 144 | xsl144X01/primary_doc.xml | 0001415889-24-022989 | 001-39503 | 241282673 | 33 | 4757 | |||
| 2024-09-05 | 4 | xslF345X05/form4-09052024_110900.xml | 0001415889-24-022987 | 10557 | ||||||
| 2024-09-05 | 4 | xslF345X05/form4-09052024_110919.xml | 0001415889-24-022986 | 8494 | ||||||
| 2024-09-05 | 4 | xslF345X05/form4-09052024_110908.xml | 0001415889-24-022985 | 10787 | ||||||
| 2024-09-05 | 4 | xslF345X05/form4-09052024_110917.xml | 0001415889-24-022984 | 10761 | ||||||
| 2024-09-05 | 4 | xslF345X05/form4-09052024_110923.xml | 0001415889-24-022983 | 11114 | ||||||
| 2024-09-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-102788 | 001-39503 | 241273923 | 34 | 7826035 | 1 | 1 |
| 2024-08-09 | 10-Q/A | 10-Q/A | 0000950170-24-094738 | 001-39503 | 241192532 | 34 | 1722788 | 1 | 1 | |
| 2024-08-01 | 10-Q | 10-Q | 0000950170-24-089304 | 001-39503 | 241166889 | 34 | 7644289 | 1 | 1 | |
| 2024-08-01 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-089281 | 001-39503 | 241166711 | 34 | 320872 | 1 | 1 |
| 2024-06-25 | 4 | xslF345X05/form4-06252024_110651.xml | 0001415889-24-018177 | 7081 | ||||||
| 2024-05-29 | 8-K | 8-K | 5.07,9.01 | 0000950170-24-065914 | 001-39503 | 24998308 | 34 | 192026 | 1 | 1 |
| 2024-05-24 | 4 | xslF345X05/form4-05242024_110538.xml | 0001415889-24-014582 | 5687 | ||||||
| 2024-05-24 | 4 | xslF345X05/form4-05242024_110543.xml | 0001415889-24-014580 | 5693 | ||||||
| 2024-05-24 | 4 | xslF345X05/form4-05242024_100557.xml | 0001415889-24-014578 | 5685 | ||||||
| 2024-05-24 | 4 | xslF345X05/form4-05242024_100520.xml | 0001415889-24-014576 | 5646 | ||||||
| 2024-05-24 | 4 | xslF345X05/form4-05242024_100543.xml | 0001415889-24-014573 | 5657 | ||||||
| 2024-05-24 | 4 | xslF345X05/form4-05242024_100527.xml | 0001415889-24-014571 | 5691 | ||||||
| 2024-05-24 | 4 | xslF345X05/form4-05242024_100557.xml | 0001415889-24-014569 | 5553 | ||||||
| 2024-05-17 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-061837 | 001-39503 | 24961061 | 34 | 200233 | 1 | 1 |
| 2024-05-15 | 10-Q | 10-Q | 0000950170-24-060482 | 001-39503 | 24950967 | 34 | 7191641 | 1 | 1 | |
| 2024-05-15 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-060452 | 001-39503 | 24950668 | 34 | 341538 | 1 | 1 |
| 2024-04-16 | 4 | xslF345X05/form4-04162024_080456.xml | 0001415889-24-010877 | 5765 | ||||||
| 2024-04-16 | 3 | xslF345X02/form3-04162024_080435.xml | 0001415889-24-010876 | 3222 | ||||||
| 2024-04-09 | ARS | ARS | 0001140361-24-018754 | 001-39503 | 24831231 | 34 | 4963732 | |||
| 2024-04-09 | DEFA14A | DEFA14A | 0001140361-24-018752 | 001-39503 | 24831228 | 34 | 773463 | |||
| 2024-04-09 | DEF 14A | DEF 14A | 0001140361-24-018750 | 001-39503 | 24831225 | 34 | 3629265 | |||
| 2024-03-28 | PRE 14A | PRE 14A | 0001140361-24-015918 | 001-39503 | 24793793 | 34 | 3520446 | |||
| 2024-02-22 | S-8 | S-8 | 0000950170-24-018825 | 333-277276 | 24665416 | 33 | 482206 | |||
| 2024-02-22 | 10-K | 10-K | 0000950170-24-018787 | 001-39503 | 24664994 | 34 | 12023651 | 1 | 1 | |
| 2024-02-22 | 8-K | 8-K | 2.02,5.02,7.01,9.01 | 0000950170-24-018764 | 001-39503 | 24664805 | 34 | 833368 | 1 | 1 |
| 2024-02-16 | 4 | xslF345X05/form4-02162024_100218.xml | 0001415889-24-004166 | 5636 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4-02162024_100213.xml | 0001415889-24-004165 | 5655 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4-02162024_090202.xml | 0001415889-24-004159 | 5673 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4-02162024_090245.xml | 0001415889-24-004158 | 5680 | ||||||
| 2024-02-16 | 4 | xslF345X05/form4-02162024_090230.xml | 0001415889-24-004157 | 5690 | ||||||
| 2024-02-16 | 4/A | xslF345X05/form4a-02162024_090222.xml | 0001415889-24-004155 | 8520 | ||||||
| 2024-02-16 | 4/A | xslF345X05/form4a-02162024_090229.xml | 0001415889-24-004153 | 11120 | ||||||
| 2024-02-16 | 4/A | xslF345X05/form4a-02162024_090252.xml | 0001415889-24-004151 | 10786 | ||||||
| 2024-02-16 | 4/A | xslF345X05/form4a-02162024_090259.xml | 0001415889-24-004149 | 8585 | ||||||
| 2024-02-16 | 4/A | xslF345X05/form4a-02162024_090254.xml | 0001415889-24-004146 | 13360 | ||||||
| 2024-02-14 | SC 13G | SC 13G | 0001104659-24-023744 | 005-91705 | 24638762 | 34 | 106457 | |||
| 2024-01-08 | 4 | FORM 4 SUBMISSION | 0001209191-24-001157 | 6064 | ||||||
| 2024-01-08 | 4 | FORM 4 SUBMISSION | 0001209191-24-001153 | 8255 | ||||||
| 2024-01-08 | 4 | FORM 4 SUBMISSION | 0001209191-24-001150 | 11086 | ||||||
| 2024-01-08 | 4 | FORM 4 SUBMISSION | 0001209191-24-001145 | 10822 | ||||||
| 2024-01-08 | 4 | FORM 4 SUBMISSION | 0001209191-24-001142 | 13103 | ||||||
| 2024-01-08 | 4 | FORM 4 SUBMISSION | 0001209191-24-001138 | 8476 | ||||||
| 2024-01-08 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-24-002686 | 001-39503 | 24518316 | 34 | 488113 | 1 | 1 |
| 2023-12-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-023291 | 13227 | ||||||
| 2023-12-29 | SC 13D/A | SC 13D/A | 0001193125-23-306018 | 005-91705 | 231528565 | 34 | 60387 | |||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062082 | 001-39503 | 231392649 | 34 | 8687696 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-062045 | 001-39503 | 231392459 | 34 | 361303 | 1 | 1 |
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-041346 | 001-39503 | 231159718 | 34 | 9505018 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-041320 | 001-39503 | 231159441 | 34 | 390656 | 1 | 1 |
| 2023-07-07 | SC 13G/A | us04746l1044_070723.txt | 0001306550-23-009576 | 005-91705 | 231077297 | 34 | 12400 | |||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-035951 | 8929 | ||||||
| 2023-06-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-034887 | 16208 | ||||||
| 2023-06-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-034886 | 9418 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031580 | 7719 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031576 | 7730 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031572 | 7683 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031566 | 7740 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031559 | 7696 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031557 | 7605 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031554 | 7722 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031552 | 8361 | ||||||
| 2023-05-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-031550 | 4828 | ||||||
| 2023-05-22 | 8-K | 8-K | 5.02,5.07,8.01,9.01 | 0001193125-23-149921 | 001-39503 | 23942465 | 34 | 545831 | 1 | 1 |
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021274 | 001-39503 | 23911319 | 34 | 9034937 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-021239 | 001-39503 | 23911121 | 34 | 379639 | 1 | 1 |
| 2023-04-20 | SC 13G | SCHEDULE 13G | 0000899140-23-000543 | 005-91705 | 23834039 | 34 | 36384 | |||
| 2023-04-05 | ARS | ARS | 0001140361-23-016531 | 001-39503 | 23801171 | 34 | 7960836 | |||
| 2023-04-05 | DEFA14A | FORM DEFA14A | 0001140361-23-016529 | 001-39503 | 23801169 | 34 | 887064 | |||
| 2023-04-05 | DEF 14A | DEF 14A | 0001140361-23-016527 | 001-39503 | 23801166 | 34 | 1565034 | |||
| 2023-03-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-021878 | 7311 | ||||||
| 2023-03-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-021708 | 4613 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021248 | 7064 | ||||||
| 2023-03-23 | S-8 | S-8 | 0000950170-23-009530 | 333-270792 | 23756743 | 33 | 567753 | |||
| 2023-03-23 | 10-K | 10-K | 0000950170-23-009498 | 001-39503 | 23756398 | 34 | 15651626 | 1 | 1 | |
| 2023-03-23 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-009483 | 001-39503 | 23756257 | 34 | 418413 | 1 | 1 |
| 2023-02-14 | SC 13G/A | ATHIRA PHARMA, INC. | 0000902664-23-001740 | 005-91705 | 23624083 | 34 | 64210 | |||
| 2023-02-01 | SC 13G/A | us04746l1044_020123.txt | 0001306550-23-006417 | 005-91705 | 23577468 | 34 | 13182 | |||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005818 | 10552 | ||||||
| 2023-01-30 | SC 13G/A | athi22a1.htm | 0000038777-23-000012 | 005-91705 | 23566608 | 34 | 186597 | |||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-004481 | 5520 | ||||||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-004480 | 5496 | ||||||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-004478 | 5467 | ||||||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-004475 | 5528 | ||||||
| 2023-01-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-004468 | 7904 | ||||||
| 2023-01-06 | 8-K | 8-K | 1.01,2.02,9.01 | 0000950170-23-000364 | 001-39503 | 23516056 | 34 | 809709 | 1 | 1 |
| 2023-01-06 | 424B5 | 424B5 | 0000950170-23-000361 | 333-261073 | 23516033 | 33 | 1787264 | |||
| 2022-12-30 | 4 | FORM 4 SUBMISSION | 0001209191-22-063009 | 7420 | ||||||
| 2022-12-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-060128 | 5041 | ||||||
| 2022-11-18 | 8-K | 8-K | 5.03,9.01 | 0000950170-22-025442 | 001-39503 | 221401965 | 34 | 572725 | 1 | 1 |
| 2022-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-057721 | 4628 | ||||||
| 2022-11-10 | 10-Q | 10-Q | 0000950170-22-024499 | 001-39503 | 221377586 | 34 | 10000619 | 1 | 1 | |
| 2022-11-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-024464 | 001-39503 | 221377279 | 34 | 417491 | 1 | 1 |
| 2022-10-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-054950 | 7034 | ||||||
| 2022-10-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-053869 | 7034 | ||||||
| 2022-10-17 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-019592 | 001-39503 | 221312607 | 34 | 1325205 | 1 | 1 |
| 2022-08-15 | 10-Q | 10-Q | 0000950170-22-017421 | 001-39503 | 221166806 | 34 | 10076299 | 1 | 1 | |
| 2022-08-15 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-017392 | 001-39503 | 221166157 | 34 | 417852 | 1 | 1 |
| 2022-07-01 | SC 13D/A | SC 13D/A | 0001193125-22-187269 | 005-91705 | 221062058 | 34 | 62308 | |||
| 2022-07-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-015719 | 11032 | ||||||
| 2022-06-30 | 4 | FORM 4 SUBMISSION | 0001209191-22-039937 | 4627 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039344 | 10473 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039343 | 8068 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039342 | 10423 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039340 | 13099 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039338 | 8126 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039336 | 8104 | ||||||
| 2022-06-22 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-011935 | 001-39503 | 221029942 | 34 | 2250673 | 1 | 1 |
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036067 | 9401 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032699 | 5577 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032696 | 5576 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032693 | 5535 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032690 | 5595 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032687 | 5450 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032684 | 5587 | ||||||
| 2022-05-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-032681 | 5543 | ||||||
| 2022-05-27 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-013738 | 7962 | ||||||
| 2022-05-24 | 8-K | 8-K | 5.07 | 0001193125-22-158630 | 001-39503 | 22957880 | 34 | 163873 | 1 | 1 |
| 2022-05-17 | DEFA14A | DEFA14A | 0001193125-22-152368 | 001-39503 | 22932149 | 34 | 16239 | |||
| 2022-05-17 | DEFA14A | DEFA14A | 0001193125-22-152128 | 001-39503 | 22931557 | 34 | 29285 | |||
| 2022-05-16 | DFAN14A | DFAN 14A | 0000899140-22-000523 | 001-39503 | 22927631 | 34 | 32897 | |||
| 2022-05-12 | 10-Q | 10-Q | 0000950170-22-009683 | 001-39503 | 22918104 | 34 | 8463978 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-009670 | 001-39503 | 22917930 | 34 | 415469 | 1 | 1 |
| 2022-05-12 | DFAN14A | DFAN 14A | 0000899140-22-000521 | 001-39503 | 22917146 | 34 | 60069 | |||
| 2022-05-11 | DEFA14A | DEFA14A | 0001193125-22-147598 | 001-39503 | 22914459 | 34 | 48886 | |||
| 2022-05-09 | DEFA14A | DEFA14A | 0001193125-22-145053 | 001-39503 | 22905570 | 34 | 27759 | |||
| 2022-05-05 | DEFA14A | DEFA14A | 0001193125-22-142271 | 001-39503 | 22896005 | 34 | 60211 | |||
| 2022-05-05 | DFAN14A | SCHEDULE 14A INFORMATION | 0000899140-22-000504 | 001-39503 | 22894816 | 34 | 41100 | |||
| 2022-05-05 | DEFA14A | DEFA14A | 0001193125-22-141398 | 001-39503 | 22894208 | 34 | 29774 | |||
| 2022-05-05 | DEFA14A | DEFA14A | 0001193125-22-141396 | 001-39503 | 22894192 | 34 | 56826 | |||
| 2022-05-04 | DFAN14A | DFAN 14A | 0000899140-22-000499 | 001-39503 | 22890382 | 34 | 37608 | |||
| 2022-05-02 | DFAN14A | SCHEDULE DFAN14A - DEFINITIVE ADDITIONAL MATERIALS | 0000899140-22-000492 | 001-39503 | 22883022 | 34 | 30040 | |||
| 2022-04-27 | DFAN14A | SCHEDULE 14A INFORMATION | 0000899140-22-000481 | 001-39503 | 22858901 | 34 | 80175 | |||
| 2022-04-26 | DEFA14A | DEFA14A | 0001193125-22-118948 | 001-39503 | 22851856 | 34 | 67559 | |||
| 2022-04-26 | DEFA14A | DEFA14A | 0001193125-22-118943 | 001-39503 | 22851848 | 34 | 9965682 | |||
| 2022-04-25 | DFAN14A | SCHEDULE 14A INFORMATION | 0000899140-22-000479 | 001-39503 | 22849534 | 34 | 12270275 | |||
| 2022-04-22 | DFAN14A | SCHEDULE 14A INFORMATION | 0000899140-22-000469 | 001-39503 | 22844020 | 34 | 1403661 | |||
| 2022-04-20 | DEFA14A | DEFA14A | 0001193125-22-111084 | 001-39503 | 22838028 | 34 | 813883 | |||
| 2022-04-13 | DFAN14A | SCHEDULE 14A INFORMATION | 0000899140-22-000464 | 001-39503 | 22825473 | 34 | 46211 | |||
| 2022-04-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-024219 | 7042 | ||||||
| 2022-04-11 | DEFA14A | DEFA14A | 0001193125-22-101729 | 001-39503 | 22820071 | 34 | 12189 | |||
| 2022-04-11 | DEFA14A | DEFA14A | 0001193125-22-101725 | 001-39503 | 22820051 | 34 | 13966549 | |||
| 2022-04-11 | DFAN14A | DFAN14A | 0001193125-22-101062 | 001-39503 | 22818569 | 34 | 36570 | |||
| 2022-04-11 | DEFC14A | DEFC14A | 0001193125-22-101009 | 001-39503 | 22818546 | 34 | 359802 | |||
| 2022-04-08 | PREC14A | PREC14A | 0001193125-22-100161 | 001-39503 | 22817264 | 34 | 360694 | |||
| 2022-04-06 | UPLOAD | filename1.pdf | 0000000000-22-003709 | 46248 | ||||||
| 2022-04-05 | DEFA14A | DEFA14A | 0001193125-22-096282 | 001-39503 | 22807941 | 34 | 58389 | |||
| 2022-04-05 | DEFC14A | DEFC14A | 0001564590-22-013569 | 001-39503 | 22806833 | 34 | 1592040 | |||
| 2022-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-022001 | 4571 | ||||||
| 2022-03-30 | PREC14A | PREC14A | 0001193125-22-090028 | 001-39503 | 22787839 | 34 | 366193 | |||
| 2022-03-30 | DEFA14A | DEFA14A | 0001564590-22-012590 | 001-39503 | 22786331 | 34 | 144934 | |||
| 2022-03-30 | DFAN14A | DFAN14A | 0001193125-22-088943 | 001-39503 | 22783710 | 34 | 47437 | |||
| 2022-03-28 | DEFA14A | DEFA14A | 0001193125-22-086878 | 001-39503 | 22776550 | 34 | 16150 | |||
| 2022-03-28 | S-8 | S-8 | 0001564590-22-012003 | 333-263907 | 22776342 | 33 | 424479 | |||
| 2022-03-28 | 10-K | 10-K | 0000950170-22-004782 | 001-39503 | 22775582 | 34 | 17650759 | 1 | 1 | |
| 2022-03-25 | CORRESP | filename1.htm | 0001564590-22-011836 | 184379 | ||||||
| 2022-03-25 | PREC14A | PREC14A | 0001564590-22-011834 | 001-39503 | 22772396 | 34 | 1550352 | |||
| 2022-03-24 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-004547 | 001-39503 | 22766601 | 34 | 395866 | 1 | 1 |
| 2022-03-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-020266 | 5395 | ||||||
| 2022-03-21 | 3 | FORM 3 SUBMISSION | 0001209191-22-020263 | 6789 | ||||||
| 2022-03-21 | 3/A | FORM 3/A SUBMISSION | 0001209191-22-020262 | 3877 | ||||||
| 2022-03-21 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-080027 | 001-39503 | 22754209 | 34 | 187432 | 1 | 1 |
| 2022-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-011485 | 6944 | ||||||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001140361-22-005380 | 005-91705 | 22634300 | 34 | 294709 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022816 | 005-91705 | 22632058 | 34 | 196963 | |||
| 2022-02-14 | SC 13G/A | ATHIRA PHARMA, INC. | 0000902664-22-001582 | 005-91705 | 22625428 | 34 | 64707 | |||
| 2022-02-04 | SC 13G | us04746l1044_020422.txt | 0000834237-22-007252 | 005-91705 | 22593485 | 34 | 13217 | |||
| 2022-02-03 | SC 13G | athi21in.htm | 0000038777-22-000015 | 005-91705 | 22587261 | 34 | 205886 | |||
| 2022-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-005628 | 10557 | ||||||
| 2022-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-005622 | 5434 | ||||||
| 2022-01-31 | 3 | FORM 3 SUBMISSION | 0001209191-22-005614 | 6848 | ||||||
| 2022-01-31 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-22-023358 | 001-39503 | 22574159 | 34 | 308962 | 1 | 1 |
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-004129 | 5530 | ||||||
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-004123 | 5469 | ||||||
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-004122 | 5522 | ||||||
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-004120 | 7909 | ||||||
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-004118 | 7931 | ||||||
| 2022-01-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-002218 | 9275 | ||||||
| 2021-11-24 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-11-24 16:00:00 | 9999999995-21-004485 | 333-261073 | 211449040 | 33 | 1779 | ||
| 2021-11-22 | CORRESP | filename1.htm | 0001193125-21-336955 | 7791 | ||||||
| 2021-11-22 | UPLOAD | filename1.pdf | 0000000000-21-014153 | 40274 | ||||||
| 2021-11-15 | S-3 | S-3 | 0001564590-21-057000 | 333-261073 | 211410377 | 33 | 1482983 | |||
| 2021-11-10 | 10-Q | 10-Q | 0000950170-21-004091 | 001-39503 | 211396901 | 34 | 10743474 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-21-004081 | 001-39503 | 211396710 | 34 | 541337 | 1 | 1 |
| 2021-11-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-063208 | 5506 | ||||||
| 2021-11-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-063207 | 5515 | ||||||
| 2021-10-21 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-21-304002 | 001-39503 | 211337116 | 34 | 320140 | 1 | 1 |
| 2021-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-052564 | 12107 | ||||||
| 2021-08-16 | 10-Q | 10-Q | 0001564590-21-044641 | 001-39503 | 211178473 | 34 | 10834257 | 1 | 1 | |
| 2021-08-16 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-21-044631 | 001-39503 | 211178236 | 34 | 497705 | 1 | 1 |
| 2021-08-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-239806 | 001-39503 | 211154490 | 34 | 185686 | 1 | 1 |
| 2021-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-047601 | 13250 | ||||||
| 2021-06-21 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-193538 | 001-39503 | 211026911 | 34 | 196442 | 1 | 1 |
| 2021-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-041084 | 7538 | ||||||
| 2021-06-14 | 3 | FORM 3 SUBMISSION | 0001209191-21-040268 | 6951 | ||||||
| 2021-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-039627 | 9334 | ||||||
| 2021-06-10 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-039625 | 9461 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-039242 | 6954 | ||||||
| 2021-06-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-21-005266 | 8005 | ||||||
| 2021-06-01 | 3 | FORM 3 SUBMISSION | 0001209191-21-036925 | 6918 | ||||||
| 2021-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-036919 | 5342 | ||||||
| 2021-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-036916 | 5470 | ||||||
| 2021-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-036915 | 5479 | ||||||
| 2021-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-036913 | 5487 | ||||||
| 2021-06-01 | 8-K | 8-K | 5.07 | 0001564590-21-031155 | 001-39503 | 21985263 | 34 | 178006 | 1 | 1 |
| 2021-05-13 | 10-Q | 10-Q | 0001564590-21-027607 | 001-39503 | 21920249 | 34 | 9717438 | 1 | 1 | |
| 2021-05-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-21-027547 | 001-39503 | 21919721 | 34 | 485572 | 1 | 1 |
| 2021-04-16 | DEFA14A | DEFA14A | 0001564590-21-019081 | 001-39503 | 21830067 | 34 | 469348 | |||
| 2021-04-16 | DEF 14A | DEF 14A | 0001564590-21-019074 | 001-39503 | 21830020 | 34 | 2345231 | |||
| 2021-03-26 | S-8 | S-8 | 0001564590-21-015631 | 333-254735 | 21774268 | 33 | 375545 | |||
| 2021-03-25 | 10-K | 10-K | 0001564590-21-015495 | 001-39503 | 21772570 | 34 | 13400730 | 1 | ||
| 2021-03-25 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-21-015484 | 001-39503 | 21772461 | 34 | 225829 | ||
| 2021-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-018569 | 5386 | ||||||
| 2021-03-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-018560 | 6812 | ||||||
| 2021-03-08 | 8-K | 8-K | 5.02,9.01 | 0001564590-21-011353 | 001-39503 | 21720583 | 34 | 72750 | ||
| 2021-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-012823 | 5474 | ||||||
| 2021-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-012822 | 5445 | ||||||
| 2021-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-012819 | 5461 | ||||||
| 2021-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-012816 | 5469 | ||||||
| 2021-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-012813 | 5480 | ||||||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001104659-21-023916 | 005-91705 | 21638119 | 34 | 265305 |
One latest value per concept from companyfacts (227 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 13.08M | 2026-11-12 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 9.90M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 886,859 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-05-11 | 0001193125-26-216742 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 770,805 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-05-11 | 0001193125-26-216742 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 1.95M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-05-11 | 0001193125-26-216742 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 1.42M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-05-11 | 0001193125-26-216742 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 31,000 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-05-11 | 0001193125-26-216742 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 788,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 634,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | AccretionExpense | Accretion Expense | USD | 172,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001564590-21-027607 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 6.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 4.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -12,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 600.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 3.59M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 3.50M | 2020-04-01 | 2020-06-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004091 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 7.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 50.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | Assets | Assets | USD | 38.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 36.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 6,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009683 |
| us-gaap | CapitalUnitsAuthorized | Capital Units, Authorized | shares | 500.00M | 2026-03-18 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 16.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 16.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -52.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 65.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 400.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 9.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 9.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -73.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 92.54M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 |
| us-gaap | ConvertibleDebtNoncurrent | Convertible Debt, Noncurrent | USD | 1.55M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 58.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 241,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 14.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 112.86M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 25.20M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0000950170-24-018787 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 56.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 258,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 352,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 12.93M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 369,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 112.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxLiabilitiesInvestments | Deferred Tax Liabilities, Investments | USD | 19,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 109,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | Depreciation | Depreciation | USD | 678,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -445,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001564590-21-027607 |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 999,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | DueFromRelatedParties | Due from Related Parties | USD | 36,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | DueFromRelatedPartiesCurrent | Due from Related Parties, Current | USD | 7,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | DueFromRelatedPartiesNoncurrent | Due from Related Parties, Noncurrent | USD | 29,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -3.3 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.2 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0000950170-22-017421 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -3.3 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.192 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.018 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal | Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 2.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 36.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 16.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -7,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 199,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 20.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -105.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -19.95M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 20.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -22.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 669,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 759,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -2.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | IncreaseDecreaseInInsuranceSettlementsReceivable | Increase (Decrease) in Insurance Settlements Receivable | USD | -1.63M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | IncreaseDecreaseInOperatingAssets | Increase (Decrease) in Operating Assets | USD | -308,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001564590-21-027607 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -343,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -564,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 2.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | InsuranceRecoveries | Insurance Recoveries | USD | 1.63M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 |
| us-gaap | InsuranceSettlementsReceivableCurrent | Insurance Settlements Receivable, Current | USD | 1.63M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 | |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 1.66M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024499 |
| us-gaap | InterestExpense | Interest Expense | USD | 2,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009683 |
| us-gaap | InvestmentsAndCash | Investments and Cash | USD | 32.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 476,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 494,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 130,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 286,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 494,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 509,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0000950170-24-018787 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 346,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 126,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269544 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 16,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | Liabilities | Liabilities | USD | 22.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 38.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 7.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | LitigationReserve | Estimated Litigation Liability | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 4.13M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 44.83M | 2022-12-31 | 2023 | FY | 10-K | 2024-02-22 | 0000950170-24-018787 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 4.10M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 | |
| us-gaap | LossContingencyAccrualCarryingValueCurrent | Loss Contingency, Accrual, Current | USD | 10.00M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 | |
| us-gaap | LossContingencyDamagesSoughtValue | Loss Contingency, Damages Sought, Value | USD | 4.10M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 | |
| us-gaap | NetCashProvidedByUsedInContinuingOperations | Net Cash Provided by (Used in) Continuing Operations | USD | -56.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 114,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 3.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -56.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -73.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 1.65M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024499 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -58.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 265,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 265,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062082 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 460,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 460,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 338,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 21,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 308,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 227,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.081 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 259.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 64,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -8,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -33,000 | 2021-07-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004091 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -3,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 840,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 1.40M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 4,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024499 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 1.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 46,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001564590-21-027607 |
| us-gaap | PaymentsForLegalSettlements | Payments for Legal Settlements | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0000950170-25-105052 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 209,000 | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001564590-21-044641 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 7.60M | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 38.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 16.29M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-03-18 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 100.00M | 2026-03-18 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 4.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ProceedsFromCollectionOfLoansReceivable | Proceeds from Collection of Loans Receivable | USD | 36,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 1.66M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 96.76M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009498 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 89.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 90.00M | 2025-12-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 42.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecurities | Proceeds from Sale of Available-for-sale Securities | USD | 18.05M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004091 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 18.05M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009498 |
| us-gaap | ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess | Proceeds from Short-term Debt, Maturing in Three Months or Less | USD | 215,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053574 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 99,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021274 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -73.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 5.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 800,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 2,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053574 |
| us-gaap | RepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess | Repayments of Short-term Debt, Maturing in Three Months or Less | USD | 215,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053574 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 38.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 8.37M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123372 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 631,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | RestructuringAndRelatedCostCostIncurredToDate1 | Restructuring and Related Cost, Cost Incurred to Date | USD | 2.90M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | RestructuringAndRelatedCostExpectedCost1 | Restructuring and Related Cost, Expected Cost | USD | 2.90M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.7 | 2024-09-15 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269544 | |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 400,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 400,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -584.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 680,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009498 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | 8.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | SettlementLiabilitiesCurrent | Settlement Liabilities, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 2.89M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 7.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.059 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 98,723 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 41.89 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 47,513 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 27.9 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 4.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 6.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) | shares | 1.91M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-15 | 0000950170-24-060482 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 14.72 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 2.73M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-352243 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 5.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 9.2 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 4.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0.16 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 9.3 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 37.38M | 2021-12-31 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024499 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 15.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 16,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004091 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 10.59M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 16.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | StockIssued1 | Stock Issued | USD | 4.51M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 75,660 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029069 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan | Stock Issued During Period, Value, Employee Stock Ownership Plan | USD | 37,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 114,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 4.62M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004782 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 12,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 17.05M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001564590-21-015495 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 4.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 30,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009498 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 190,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 20.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134565 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 120,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 22.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 37.63M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0000950170-22-017421 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 22.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-463518 |